Netherlands· NL-acfcf583049a
Efient 5 mg filmomhulde tabletten
A prasugrel product containing prasugrelhydrochloride, registered in Netherlands by Substipharm. The same ATC class is registered in 19 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Prasugrel is registered in 19 of 19 countries.
Countries holding a registration under ATC B01AC22 (prasugrel), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 11 of them publish a price we can compare per daily dose
Prasugrel · ATC B01AC22
19 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of prasugrel costs, country by country.
Normalised to the WHO defined daily dose (10 mg), the median price runs from $0.67 in France to $3.02 in Switzerland — a ×4.5 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Prasugrel · price per daily dose (10 mg)
USD · FX 28 Sept 2026
- CH Switzerland$3.02
- IT Italy$1.61
- ES Spain$1.36
- FR France$0.67
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- PRASUGRELHYDROCHLORIDE
- Manufacturer
- Substipharm
- Country
- Netherlands (NL)
- ATC code
- B01AC22
- ATC class
- Prasugrel
- Defined daily dose
- 10 mg, O
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_idEU/1/08/503
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
219 interactions on record for prasugrel.
Graded by severity as the source publishes them — 91 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Prasugrel · interactions on record
219 records
- 91 severe
- 89 moderate
- 19 minor
Most severe, free to view
- DicoumarolB01AA01severe
- WarfarinB01AA03severe
- Antithrombin IIIB01AB02severe
- DalteparinB01AB04severe
20 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Prasugrel in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaEFIENTSubstipharm, Paris
- SpainEFIENT 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULASubstipharm
- United StatesPrasugrelAccord Healthcare Inc.
- SwedenEfient 5 mg Filmdragerad tablettSubstipharm
- IcelandEfientSubstipharm
- SwitzerlandEfient
- PolandEfientSubstipharm
- IrelandEfient 5 mg Film-coated tabletSubstipharm
Authorised across Europe · EMA
The same active substance is authorised in 26 EEA countries. Names it is sold under:
- Austria · Prasugrel Hcs, Prasugrel Ratiopharm
- Belgium · Prasugrel Krka
- Bulgaria · Eлискардиа, Бевим
- Czechia · Eliskardia
- Germany · Prafsia, Prasillt
- Denmark · Prafsia, Prasugrel Eql Pharma
- Estonia · Eliskardia, Prasugrel Alembic
- Spain · Prafsia, Prasugrel Combix
- France · Prafsia, Prasugrel Arrow
- United Kingdom (Northern Ireland) · Prasugrel, Prasugrel Accord
- Greece · Prafsia, Prasugrel Vocate
- Croatia · Eliskardia, Prasugrel Pliva
- Hungary · Bewim, Eliskardia
- Ireland · Prasugrel Accord, Prasugrel Krka
- Iceland · Efient, Prasugrel G.L. Pharma
- Italy · Drullub, Prafsia
- Liechtenstein · Efient, Prasugrel Viatris
- Lithuania · Eliskardia
- Malta · Prasugrel Vocate
- Norway · Efient, Prasugrel Eql Pharma
- Poland · Bewim, Sigrada
- Portugal · Prasugrel Pentafarma, Prasugrel Tecnigen
- Romania · Eliskardia
- Sweden · Prasugrel Eql Pharma, Prasugrel G.L. Pharma
- Slovenia · Eliskardia, Tosynal
- Slovakia · Bewim, Sigrada
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/148c78e1-00a2-404f-a290-d3dfe7b1d1e7 GET /v1/drugs/148c78e1-00a2-404f-a290-d3dfe7b1d1e7?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Filmomhulde tablet",
"route": "Oraal gebruik",
"soort": null,
"source": "cbg_meb",
"smpc_url": "https://www.ema.europa.eu/en/documents/product-information/efient-epar-product-information_nl.pdf",
"strength": null,
"atc_label": "Prasugrel",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp102195",
"excipients": [
"CELLULOSE, MICROKRISTALLIJN (E 460(i))",
"CROSCARMELLOSE NATRIUM (E 468)",
"GLYCEROLTRIACETAAT (E 1518)",
"HYPROMELLOSE (E 464)",
"HYPROMELLOSE 2910 (3 - 15 mPa.s) (E 464)",
"IJZEROXIDE GEEL (E 172)",
"LACTOSE 1-WATER",
"MAGNESIUMSTEARAAT (E 470b)",
"MANNITOL (D-) (E 421)",
"TALK (E 553b)",
"TITAANDIOXIDE (E 171)"
],
"substances": [
"PRASUGRELHYDROCHLORIDE"
],
"leaflet_url": null,
"authorised_at": "2009/02/25",
"procedure_number": "EMEA/H/C/000984",
"dispensing_status": "Uitsluitend recept",
"registration_number": "EU/1/08/503",
"additional_monitoring": "N"
}See everything about prasugrel.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.